← Back to Search

Injectable Medication Platforms for Medical Treatments

N/A

Recruiting

Led By Gaurav Gupta, MD

Research Sponsored by Canadian Forces Health Services Centre Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after intervention

Awards & highlights

Study Summary

This trial is testing different types of autoinjectors to see which is the most efficient at delivering medication.

Who is the study for?

This trial is for adults over 18 who can consent and have not used medication injections in the past year. It's not for healthcare workers with recent injection experience or those with conditions affecting thinking or hand coordination, as well as anyone with recent substance use.Check my eligibility

What is being tested?

The study compares different methods of injecting emergency medications: autoinjectors, standard injectors, and prefilled syringes. The goal is to find out which method delivers medicine most efficiently during emergencies like severe allergies or overdoses.See study design

What are the potential side effects?

While the trial focuses on delivery methods rather than medications themselves, potential side effects may include pain at the injection site, bruising, allergic reactions to components of the injector device, or complications from incorrect usage.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in medication Injection/delivery time for each trial

Secondary outcome measures

Number of injection failures and/or injuries associated with each trial

Perceived difficulty of injection based on type of system

Trial Design

1Treatment groups

Experimental Treatment

Group I: Injection ScenarioExperimental Treatment3 Interventions

For each scenario participants will be asked to administer/inject the "medication" (likely saline or air) using various methods: 1) standard protocol , 2) Autoinjector 3) Pre-filled syringes. For each scenario the appropriate medication administration type will have to be selected amongst groups of options: 1) autoinjectors equivalents (ie medication, needle and syringe attached) 2) prefilled syringes where a needle is attached prior to administration; and 3) standard protocol (i.e. drawing medication from the vial and injecting via syringe/22 gauge needle). Medications options will include 1) Naloxone (opioid overdose) 2) Epinephrine (anaphylaxis) 3) Tranexamic acid (bleeding).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Autoinjector

2016

Completed Phase 3

~440

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Canadian Forces Health Services Centre OttawaLead Sponsor

9 Previous Clinical Trials

1,199 Total Patients Enrolled

Gaurav Gupta, MDPrincipal InvestigatorCAF

5 Previous Clinical Trials

207 Total Patients Enrolled

Media Library

Prefilled Clinical Trial Eligibility Overview. Trial Name: NCT05367531 — N/A

Bleeding Research Study Groups: Injection Scenario

Bleeding Clinical Trial 2023: Prefilled Highlights & Side Effects. Trial Name: NCT05367531 — N/A

Prefilled 2023 Treatment Timeline for Medical Study. Trial Name: NCT05367531 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a way I can become involved in this investigation?

"This particular medical trial is allowing 30 individuals aged 18 to 85 with bleeding-related issues to take part in the study. The most important requirement for eligibility is that all participants must be over the age of consent and have been granted permission by their legal guardian or carer."

Answered by AI

Are there any vacancies for enrolled participants in this clinical trial?

"Affirmative. Clinicaltrials.gov has the latest information that this research, initially posted on April 30th 2022, is actively recruiting participants. This study needs to find thirty individuals at one site of enrollment."

Answered by AI

Does this experiment encompass individuals of senior age?

"This particular medical trial requires participants to be between 18 and 85 years of age."

Answered by AI

How many participants can take part in the clinical experiment?

"Affirmative. The information available on clinicaltrials.gov reports that this medical trial, which was initially posted April 30th 2022 is currently accepting participants. A total of thirty individuals will be recruited from a single centre for the purpose of the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Injectable Medication Platforms

Gaurav Gupta 2022. "Assessment of Injectable Medication Platforms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05367531.

All > Penicillin Allergy > Allergy